» Articles » PMID: 31803611

The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism

Overview
Journal Front Oncol
Specialty Oncology
Date 2019 Dec 6
PMID 31803611
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolism encompasses the biochemical processes that allow healthy cells to keep energy, redox balance and building blocks required for cell development, survival, and proliferation steady. Malignant cells are well-documented to reprogram their metabolism and energy production networks to support rapid proliferation and survival in harsh conditions via mutations in oncogenes and inactivation of tumor suppressor genes. Despite the histologic and genetic heterogeneity of tumors, a common set of metabolic pathways sustain the high proliferation rates observed in cancer cells. This review with a focus on lung cancer covers several fundamental principles of the disturbed glucose metabolism, such as the "Warburg" effect, the importance of the glycolysis and its branching pathways, the unanticipated gluconeogenesis and mitochondrial metabolism. Furthermore, we highlight our current understanding of the disturbed glucose metabolism and how this might result in the development of new treatments.

Citing Articles

A method for the identification of lactate metabolism-related prognostic biomarkers and its validations in non-small cell lung cancer.

Yang W, Gu M, Zhang Y, Zhang Y, Liu T, Wu D Sci Rep. 2025; 15(1):5812.

PMID: 39962075 PMC: 11832748. DOI: 10.1038/s41598-025-85620-z.


Targeting glycolysis: exploring a new frontier in glioblastoma therapy.

Yang L, Li S, Yu L, Leng J, Li N Front Immunol. 2025; 15:1522392.

PMID: 39877360 PMC: 11772265. DOI: 10.3389/fimmu.2024.1522392.


PFKFB3-dependent redox homeostasis and DNA repair support cell survival under EGFR-TKIs in non-small cell lung carcinoma.

Lypova N, Dougherty S, Clem B, Feng J, Yin X, Zhang X Cancer Metab. 2024; 12(1):37.

PMID: 39696407 PMC: 11658331. DOI: 10.1186/s40170-024-00366-y.


Targeting Lactate: An Emerging Strategy for Macrophage Regulation in Chronic Inflammation and Cancer.

Jiang R, Ren W, Wang L, Zhang W, Jiang Z, Zhu G Biomolecules. 2024; 14(10).

PMID: 39456135 PMC: 11505598. DOI: 10.3390/biom14101202.


Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance.

Qin R, Fan X, Huang Y, Chen S, Ding R, Yao Y Transl Oncol. 2024; 50():102156.

PMID: 39405607 PMC: 11736406. DOI: 10.1016/j.tranon.2024.102156.


References
1.
Ooi A, Gomperts B . Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA. Clin Cancer Res. 2015; 21(11):2440-4. PMC: 4452440. DOI: 10.1158/1078-0432.CCR-14-1209. View

2.
Ruan H, Singh J, Li M, Wu J, Yang X . Cracking the O-GlcNAc code in metabolism. Trends Endocrinol Metab. 2013; 24(6):301-9. PMC: 3783028. DOI: 10.1016/j.tem.2013.02.002. View

3.
Finicle B, Jayashankar V, Edinger A . Nutrient scavenging in cancer. Nat Rev Cancer. 2018; 18(10):619-633. DOI: 10.1038/s41568-018-0048-x. View

4.
Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F . Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today (Barc). 2003; 39(3):157-74. DOI: 10.1358/dot.2003.39.3.799451. View

5.
Marchiq I, Le Floch R, Roux D, Simon M, Pouyssegur J . Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin. Cancer Res. 2014; 75(1):171-80. DOI: 10.1158/0008-5472.CAN-14-2260. View